Updates are available Correction dated 2019-11-05
Click to view Correction: https://doi.org/10.1038/s41551-019-0483-3
-
Authors
Shaheen, Mohammed F. http://orcid.org/0000-0002-5093-3998
Joo, Dong Jin http://orcid.org/0000-0001-8405-1531
Ross, Jeffrey J. http://orcid.org/0000-0001-8185-5905
Anderson, Brett D.
Chen, Harvey S.
Huebert, Robert C. http://orcid.org/0000-0002-9812-7573
Li, Yi
Amiot, Bruce
Young, Anne
Zlochiver, Viviana
Nelson, Erek
Mounajjed, Taofic
Dietz, Allan B. http://orcid.org/0000-0003-3410-9621
Michalak, Gregory
Steiner, Benjamin G.
Davidow, Dominique Seetapun
Paradise, Christopher R. http://orcid.org/0000-0002-5882-709X
van Wijnen, Andre J.
Shah, Vijay H.
Liu, Mengfei http://orcid.org/0000-0001-7156-5082
Nyberg, Scott L. http://orcid.org/0000-0002-5005-3050
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Information Technology (R01DK117861, R03DK113339, R01DK106667)
- License Information
-
More Information
Article History
Received: 14 November 2018
Accepted: 11 September 2019
First Online: 14 October 2019
Change Date: 5 November 2019
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41551-019-0483-3
Competing interests
: Miromatrix Medical Inc. is a privately funded company and owns the patent rights for the perfusion decellularization and recellularization technologies employed in this study. The research was funded by Miromatrix and a Mayo Clinic Innovation grant. J.J.R., B.D.A., A.Y., B.G.S. and D.S.D. are employees of Miromatrix.
